Buscar resultados de ensayos clínicos

Patrocinado por

Anaplastic Oligoastrocytoma - 21 Studies Found

Estado Estudiar
Active, not recruiting Nombre del estudio: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
Condición:
  • Anaplastic Astrocytoma
  • Anaplastic Oligodendroglioma
  • Fecha: 2012-07-04
    Intervenciones:
    • Drug: Carmustine(BCNU) Carmust
Active, not recruiting Nombre del estudio: Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Condición:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Anaplastic
    Fecha: 2013-11-08
    Intervenciones: Biological: Toca 511 All subjects will receive Toca 511, a retroviral replicating vector that expresses
Active, not recruiting Nombre del estudio: Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Condición:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Anaplastic
    Fecha: 2011-11-04
    Intervenciones: Biological: Toca 511 All subjects will receive Toca 511, a retroviral replicating vector that expresses
Completed Nombre del estudio: Sorafenib in Newly Diagnosed High Grade Glioma
Condición:
  • Glioblastoma
  • Gliosarcoma
  • Anaplastic Astrocytoma
  • Fecha: 2009-04-17
    Intervenciones: Drug: Sorafenib dose escalation Sorafenib dose escalation scheme: 3 first patients: 200 mg/d, if dose li
Terminated Nombre del estudio: Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
Condición:
  • Anaplastic Astrocytoma
  • Anaplastic Oligodendroglioma
  • Fecha: 2014-05-29
    Intervenciones:
    • Dietary Supplement: ascorbic acid

Completed Nombre del estudio: BIBF 1120 for Recurrent High-Grade Gliomas
Condición:
  • Glioblastoma
  • Gliosarcoma
  • Anaplastic Astrocytoma
  • Fecha: 2011-06-21
    Intervenciones: Drug: BIBF 1120 200 mg BID oral for 28 day cycle
Terminated Nombre del estudio: Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols
Condición:
  • Glioblatoma
  • Gliosarcoma
  • Anaplastic Astrocytoma
  • Fecha: 2002-05-02
Recruiting Nombre del estudio: WEE1 Inhibitor AZD1775 and Local Radiation Therapy in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Condición:
  • Diffuse Intrinsic Pontine Glioma
  • Untreated Childhood Anaplastic Astrocytoma
  • Other: Laboratory Biomarker Analysis

Terminated Nombre del estudio: Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
Condición:
  • High Grade Glioma: Glioblastoma (GBM)
  • High Grade Glioma: Gliosarcoma
  • Drug: Plerixafor Given subcuta
Not yet recruiting Nombre del estudio: Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Condición:
  • Malignant Glioma
  • Anaplastic Astrocytoma